NCT01468623 2023-07-19
PROFUSE
Myriad Genetic Laboratories, Inc.
Phase 4 Terminated
Clinical Trials
4 trialsNCT03831633 2019-02-06
Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients
VIFORFRANCE
Phase 4 Unknown
NCT02034799 2018-02-26
Phase IV Bioseal Study in Brain Tumor Surgery
Ethicon, Inc.
Phase 4 Completed
NCT00224068 2012-03-02
Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy
Watson Pharmaceuticals
Phase 4 Completed